R

Radiopharm Theranostics Ltd
ASX:RAD

Watchlist Manager
Radiopharm Theranostics Ltd
ASX:RAD
Watchlist
Price: 0.021 AUD Market Closed
Market Cap: 49m AUD

Wall Street
Price Targets

RAD Price Targets Summary
Radiopharm Theranostics Ltd

There are no price targets for RAD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Radiopharm Theranostics Ltd Competitors:
Price Targets
TWST
Twist Bioscience Corp
35% Upside
IKT
Inhibikase Therapeutics Inc
306% Upside
ZEAL
Zealand Pharma A/S
154% Upside
688177
Bio-Thera Solutions Ltd
2% Downside
600201
Jinyu Bio-Technology Co Ltd
2% Upside
DVAX
Dynavax Technologies Corp
126% Upside
CYTK
Cytokinetics Inc
121% Upside
AKBA
Akebia Therapeutics Inc
103% Upside

Revenue
Forecast

Revenue Estimate
Radiopharm Theranostics Ltd

The compound annual growth rate of Radiopharm Theranostics Ltd's revenue for the next 4 years is 259%.

N/A
Past Growth
259%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Radiopharm Theranostics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat

Net Income
Forecast

Net Income Estimate
Radiopharm Theranostics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAD's stock price target?
Not Available

RAD doesn't have any price targets made by Wall Street professionals.

What is Radiopharm Theranostics Ltd's Revenue forecast?
Projected CAGR
259%

The compound annual growth rate of Radiopharm Theranostics Ltd's revenue for the next 4 years is 259%.

Back to Top